398 related articles for article (PubMed ID: 27862370)
1. Comparative evaluation of pan-fungal real-time PCR, galactomannan and (1-3)-β-D-glucan assay for invasive fungal infection in paediatric cancer patients.
Gupta P; Ahmad A; Khare V; Kumar A; Banerjee G; Verma N; Singh M
Mycoses; 2017 Apr; 60(4):234-240. PubMed ID: 27862370
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
[TBL] [Abstract][Full Text] [Related]
3. Screening of invasive fungal infections by a real-time panfungal (pan-ACF) polymerase chain reaction assay in patients with haematological malignancy.
Capoor MR; Puri S; Raheja H; Mohindra R; Gupta DK; Verma PK; Chowdhary R
Indian J Med Microbiol; 2017; 35(1):41-47. PubMed ID: 28303817
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of biomarkers: Galactomannan and 1,3-beta-D-glucan assay for the diagnosis of invasive fungal infections in immunocompromised patients from a tertiary care centre.
Singh S; Kaur H; Choudhary H; Sethi S; Malhotra P; Gupta KL; Rudramurthy SM; Chakrabarti A
Indian J Med Microbiol; 2018; 36(4):557-563. PubMed ID: 30880706
[TBL] [Abstract][Full Text] [Related]
5. Comparative accuracy of 1,3 beta-D glucan and galactomannan for diagnosis of invasive fungal infections in pediatric patients: a systematic review with meta-analysis.
Singh S; Singh M; Verma N; Sharma M; Pradhan P; Chauhan A; Jaiswal N; Chakrabarti A; Singh M
Med Mycol; 2021 Feb; 59(2):139-148. PubMed ID: 32448907
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
Aydoğan S; Kuştimur S; Kalkancı A
Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients.
El-Mahallawy HA; Shaker HH; Ali Helmy H; Mostafa T; Razak Abo-Sedah A
Med Mycol; 2006 Dec; 44(8):733-9. PubMed ID: 17127630
[TBL] [Abstract][Full Text] [Related]
8. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Values and Limitations of (1,3)-β-D-Glucans and Galactomannan Assays for Invasive Fungal Infection in Patients Admitted to Pediatric Intensive Care Unit.
Zheng F; Zha H; Yang D; Deng J; Zhang Z
Mycopathologia; 2017 Apr; 182(3-4):331-338. PubMed ID: 27664106
[TBL] [Abstract][Full Text] [Related]
10. Prospective Evaluation of Galactomannan and (1→3) β-d-Glucan Assays as Diagnostic Tools for Invasive Fungal Disease in Children, Adolescents, and Young Adults With Acute Myeloid Leukemia Receiving Fungal Prophylaxis.
Fisher BT; Westling T; Boge CLK; Zaoutis TE; Dvorak CC; Nieder M; Zerr DM; Wingard JR; Villaluna D; Esbenshade AJ; Alexander S; Gunn S; Wheat LJ; Sung L
J Pediatric Infect Dis Soc; 2021 Sep; 10(8):864-871. PubMed ID: 34173659
[TBL] [Abstract][Full Text] [Related]
11. [Utility of galactomannan enzyme immunoassay and (1,3)beta-D-glucan assay in invasive fungal infection].
Yu J; Li RY; Gao LJ; Lu QY; Wang XH
Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(6):371-4. PubMed ID: 20367931
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of galactomannan and beta-d-glucan assays for the diagnosis of invasive aspergillosis in clinically suspected cases.
Sarwar M; Gardezi SAH; Zaman G; Ikram A; Satti L; Khadim MT
J Pak Med Assoc; 2020 Mar; 70(3):442-446. PubMed ID: 32207422
[TBL] [Abstract][Full Text] [Related]
13. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T
Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310
[TBL] [Abstract][Full Text] [Related]
14. Detection of β-D-glucan for the diagnosis of invasive fungal infection in children with hematological malignancy.
Guitard J; Tabone MD; Senghor Y; Cros C; Moissenet D; Markowicz K; Valin N; Leverger G; Hennequin C
J Infect; 2016 Dec; 73(6):607-615. PubMed ID: 27452196
[TBL] [Abstract][Full Text] [Related]
15. The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections.
Metan G; Ağkuş C; Buldu H; Koç AN
Infection; 2010 Jun; 38(3):217-21. PubMed ID: 20237947
[TBL] [Abstract][Full Text] [Related]
16. β-1,3-d-Glucan and Galactomannan as Biomarkers for the Detection of Invasive
Forster J; Koc Ö; Koeppel MB; Hamprecht A; Kurzai O; Suerbaum S; Wagener J; Dichtl K
J Clin Microbiol; 2022 Jan; 60(1):e0160721. PubMed ID: 34669454
[No Abstract] [Full Text] [Related]
17. Evaluation of Mass Spectrometry-Based Detection of Panfungal Serum Disaccharide for Diagnosis of Invasive Fungal Infections: Results from a Collaborative Study Involving Six European Clinical Centers.
Cornu M; Sendid B; Mery A; François N; Mikulska M; Letscher-Bru V; De Carolis E; Damonti L; Titecat M; Bochud PY; Alanio A; Sanguinetti M; Viscoli C; Herbrecht R; Guerardel Y; Poulain D
J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30787140
[TBL] [Abstract][Full Text] [Related]
18. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.
Kawazu M; Kanda Y; Nannya Y; Aoki K; Kurokawa M; Chiba S; Motokura T; Hirai H; Ogawa S
J Clin Microbiol; 2004 Jun; 42(6):2733-41. PubMed ID: 15184460
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.
Pini P; Bettua C; Orsi CF; Venturelli C; Forghieri F; Bigliardi S; Faglioni L; Luppi F; Serio L; Codeluppi M; Luppi M; Mussini C; Girardis M; Blasi E
Infection; 2016 Apr; 44(2):223-33. PubMed ID: 26475482
[TBL] [Abstract][Full Text] [Related]
20. Use of Galactomannan Antigen and Aspergillus DNA Real-time Polymerase Chain Reaction as Routine Methods for Invasive Aspergillosis in Immunosuppressed Children in Greece.
Vrioni G; Theodoridou K; Tsiamis C; Mavrouli M; Kapsimali V; Rigopoulos D; Tsakris A
Clin Ther; 2018 Jun; 40(6):918-924.e2. PubMed ID: 29807668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]